Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Pablo Roblero

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Hepatology|July 15, 2026
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosisSimone Incicco, Kavish R Patidar, Adrià Juanola, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
The Lancet. Gastroenterology & Hepatology|March 9, 2025
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort studyKavish R Patidar, Ann T Ma, Adrià Juanola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal SyndromeAnn T Ma, Adrià Juanola, Kavish R Patidar, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Hepatology|July 15, 2026
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosisSimone Incicco, Kavish R Patidar, Adrià Juanola, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
The Lancet. Gastroenterology & Hepatology|March 9, 2025
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort studyKavish R Patidar, Ann T Ma, Adrià Juanola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal SyndromeAnn T Ma, Adrià Juanola, Kavish R Patidar, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 3